In March 2022, Bharat Biotech partnered with which country's bio-pharmaceutical firm Biofabri for TB vaccine?
AAustralia
BUSA
CCanada
DSpain
Answer:
D. Spain
Read Explanation:
Bharat Biotech has started Phase 3 trials of the first live attenuated vaccine of Mycobacterium TB isolated from a human strain, Spanish biopharma firm Biofabri has completed Phase 1-2 in other countries.
Clinical trials of Spanish tuberculosis (TB) vaccine MTBVAC have begun in India.The partnership between Bharat Biotech and Biofabri aims to develop a new tuberculosis (TB) vaccine, which is a major public health concern globally.
TB is a bacterial infection that primarily affects the lungs and is spread through the air when an infected person coughs or sneezes.
It is one of the top 10 causes of death worldwide.